person

WELNIARZ A.

Country
France
Department
Service de Neuro-Urologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 8 partner sites.

Specializations

Neuro‑Urology & Bladder Dysfunction

The investigator focuses on disorders of urinary control linked to neurological injury, including neurogenic bladder and detrusor overactivity in multiple sclerosis or spinal cord injury.

  • Detrusor overactivity
  • Neurogenic bladder
  • Recurrent urinary tract infections
  • Spinal cord injury
  • Intermittent catheterisation

Research includes therapeutic strategies to reduce infection risk and improve bladder storage.

Neuromuscular & Muscular Dystrophies

Clinical activity encompasses rare muscle disorders such as Duchenne muscular dystrophy and spinal muscular atrophy, targeting disease‑modifying agents.

  • Duchenne muscular dystrophy
  • Spinal muscular atrophy
  • Risdiplam combination therapy
  • Gene‑based treatments
  • Motor function preservation

Efforts aim to assess safety and functional outcomes in pediatric and adult cohorts.

Infectious Diseases & Antiviral Strategies

Work includes viral co‑infection management and novel antibody approaches for HIV‑1 and hepatitis B, as well as bacterial pneumonia interventions.

  • HIV‑1 primary infection
  • HBV co‑infection
  • Broadly neutralising antibodies
  • Community‑acquired pneumonia
  • Severe bacterial pneumonia

Trials evaluate remission durability and antimicrobial stewardship.

Cerebrovascular & Stroke Prevention

Investigations address acute and secondary prevention of ischemic events, including acute ischemic stroke and high‑risk transient ischemic attack.

  • Acute ischemic stroke
  • High‑risk transient ischemic attack
  • FXIa inhibition
  • Antithrombotic therapy
  • Post‑stroke pain

Focus is on reducing recurrent events and bleeding complications.

Lysosomal Storage & Metabolic Disorders

The portfolio includes rare enzyme‑deficiency diseases such as Fabry disease and Pompe disease, exploring substrate reduction and enzyme replacement enhancements.

  • Fabry disease
  • Pompe disease
  • Enzyme replacement therapy
  • Substrate reduction therapy
  • Neuropathic pain management

Studies assess long‑term safety and quality‑of‑life outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.